Clearstead Advisors, LLC Eli Lilly & CO Transaction History

Clearstead Advisors, LLC

$6.31 Billion
Q3 2024

A detailed history of Clearstead Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Clearstead Advisors, LLC holds 34,790 shares of LLY stock, worth $26 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares

34,790

Previous 35,153 1.03%

Holding current value

$26 Million

Previous $31.8 Million 3.16%

% of portfolio

0.49%

Previous 0.55%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$772.14 - $960.02 $280,286 - $348,487	-363 Reduced 1.03%	34,790 $30.8 Million
Q2 2024 Aug 09, 2024	BUY	$724.87 - $909.04 $11 Million - $13.8 Million	15,205 Added 76.22%	35,153 $31.8 Million
Q1 2024 May 14, 2024	SELL	$592.2 - $792.28 $1.5 Million - $2.01 Million	-2,538 Reduced 11.29%	19,948 $15.5 Million
Q4 2023 Feb 12, 2024	BUY	$525.19 - $619.13 $826,649 - $974,510	1,574 Added 7.53%	22,486 $13.1 Million
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $1.09 Million - $1.5 Million	-2,507 Reduced 10.7%	20,912 $11.2 Million
Q3 2023 Nov 07, 2023	BUY	$434.7 - $599.3 $617,708 - $851,605	1,421 Added 6.46%	23,419 $12.6 Million
Q2 2023 Aug 07, 2023	BUY	$350.74 - $468.98 $1.72 Million - $2.3 Million	4,910 Added 28.73%	21,998 $10.3 Million
Q1 2023 May 09, 2023	BUY	$310.63 - $364.82 $61,815 - $72,599	199 Added 1.18%	17,088 $5.87 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $63,988 - $74,559	199 Added 1.19%	16,889 $6.18 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $771,737 - $879,475	-2,603 Reduced 13.49%	16,690 $5.4 Million
Q2 2022 Aug 12, 2022	SELL	$278.73 - $327.27 $54,909 - $64,472	-197 Reduced 1.01%	19,293 $6.26 Million
Q1 2022 May 04, 2022	BUY	$234.69 - $291.66 $577,102 - $717,191	2,459 Added 14.44%	19,490 $5.58 Million
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $129,513 - $160,727	-576 Reduced 3.27%	17,031 $4.7 Million
Q3 2021 Nov 12, 2021	BUY	$221.6 - $272.71 $29,472 - $36,270	133 Added 0.76%	17,607 $4.07 Million
Q2 2021 Aug 12, 2021	BUY	$180.55 - $233.54 $71,317 - $92,248	395 Added 2.31%	17,474 $4.01 Million
Q1 2021 May 14, 2021	BUY	$164.32 - $212.72 $13,309 - $17,230	81 Added 0.48%	17,079 $3.19 Million
Q4 2020 Feb 11, 2021	SELL	$130.46 - $172.63 $102,411 - $135,514	-785 Reduced 4.41%	16,998 $2.87 Million
Q3 2020 Nov 12, 2020	BUY	$146.22 - $169.13 $345,371 - $399,485	2,362 Added 15.32%	17,783 $2.63 Million
Q2 2020 Aug 11, 2020	BUY	$136.42 - $164.18 $60,843 - $73,224	446 Added 2.98%	15,421 $2.53 Million
Q1 2020 May 14, 2020	SELL	$119.05 - $147.35 $7,976 - $9,872	-67 Reduced 0.45%	14,975 $2.08 Million
Q4 2019 Feb 11, 2020	BUY	$106.92 - $132.43 $66,290 - $82,106	620 Added 4.3%	15,042 $1.98 Million
Q3 2019 Nov 12, 2019	BUY	$106.79 - $116.16 $47,735 - $51,923	447 Added 3.2%	14,422 $1.61 Million
Q2 2019 Aug 08, 2019	BUY	$110.79 - $129.32 $110 - $129	1 Added 0.01%	13,975 $1.55 Million
Q1 2019 May 14, 2019	BUY	$111.31 - $131.02 $4,786 - $5,633	43 Added 0.31%	13,974 $1.81 Million
Q4 2018 Feb 11, 2019	SELL	$105.9 - $118.64 $101,028 - $113,182	-954 Reduced 6.41%	13,931 $1.61 Million
Q3 2018 Nov 13, 2018	SELL	$85.86 - $107.31 $16,914 - $21,140	-197 Reduced 1.31%	14,885 $1.6 Million
Q2 2018 Aug 07, 2018	BUY	$75.7 - $86.88 $150,037 - $172,196	1,982 Added 15.13%	15,082 $1.29 Million
Q1 2018 May 14, 2018	BUY	$74.21 - $87.6 $231,609 - $273,399	3,121 Added 31.28%	13,100 $1.01 Million
Q4 2017 Feb 09, 2018	SELL	$81.94 - $87.89 $361,273 - $387,507	-4,409 Reduced 30.64%	9,979 $843,000
Q3 2017 Nov 09, 2017	BUY	$77.07 - $85.54 $1.11 Million - $1.23 Million	14,388	14,388 $1.23 Million

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $709B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearstead Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearstead Advisors, LLC with notifications on news.

Account

Clearstead Advisors, LLC Eli Lilly & CO Transaction History